About two thirds of all currently available small-molecule drugs are natural products or in some way are obtained from natural products. Since the early 1990s, coincident with the advent of combinatorial chemistry and high-throughput screening (HTS), pharmaceutical companies have moved away from naturalproduct screening to libraries of compound collections or of chemical libraries derived from combinatorial synthesis. The results of the screens have only been as good as the libraries that were screened, however, and although screening yielded leads, many of these leads have not been "druggable," leading to a dearth of new medicines. The book Natural Products, Drug Discovery and Therapeutic Medicine is timely and reveals the diversity of chemical structures available from nature for screening and drug discovery.
The book has 14 chapters, each reviewing an area of natural products in which there is future promise of new and useful drugs. Although the book is not large, it encompasses an extraordinary amount of information, covering a historical perspective, microbial and plant-derived natural products, and new technologies that address challenges historically associated with drug discovery from natural products, as well as the majority of the classes of compounds discovered to date with useful biological activity. The book gives an up-to-date description of the wealth of natural-products chemistry and also how to apply new genetic technologies, screening tools, and methods for in silico screening, enhancing the isolation of microbes that have so far not been cultured, as well as compound extraction and purification. The book is authoritative, with each chapter written by leaders in the field. Many chapters have detailed tables and figures describing the methods used, and each chapter is followed by a complete list of references that will be useful to the specialists in the field as well as to those starting their careers in this area. As such, it will benefit drug discoverers in the pharmaceutical and biotechnology industry, as well as the pharmaceutical executives who are looking to fill their pipelines.
The book is dedicated to Dr. Arnold Demain, who has worked toward the simplified and effective synthesis and production of natural products for many decades and has trained many scientists in the field. The lead chapter written by Demain is inspiring to those in drug discovery, creating a desire to "move back to nature" where chemical diversity has been achieved through evolution. His chapter has an emphasis on natural products that are microbial metabolites. In this era in which microbial resistance is increasing and the search for new antibacterial agents has shifted to the biotechnology companies with limited resources, Demain's chapter is timely, pointing the way to find new "home runs." Two chapters following Demain's review are appropriately focused on new methods that aid in screening and isolation of natural products. The application of new genetic technology for cloning, expressing, and shuffling genes allow microbes to design new, complex molecules, thus turning the metabolite evolution clock forward. These approaches are described in 3 enlightening chapters, including 1 by Dr. F. Hutchinson and 1 by S. del Cardayre highlighting the foundational "DNA shuffling" work of Dr. W. P. Stemmer. Drs. Newman and Cragg, with their long association with the National Cancer Institute, have provided a complete review of anticancer compounds derived from natural sources. The application of new molecular technologies has been useful in identifying the target or targets of compounds previously called "cytotoxic" anticancer agents. Through the discovery that tyrosine kinase inhibitors must inhibit multiple kinases to be effective therapies, it is now accepted that multiple target activities are essential to be effective in treating cancer. It is therefore not surprising that in many instances, natural products that have been successful drugs have activity at more than 1 target. With the recent withdrawal and label changes of many synthetic compounds, the comment from Dr. William Withering (1741-1799) that is referenced in 3 chapters-"Poisons in small doses are the best medicines and the best medicines in too large doses are poisonous"-is resonating 3 centuries later.
The history of natural products is rich with compounds and products. Understandably, there are a few omissions (e.g., discodermolide, which is not described as a tubulin polymerization stabilizer together with other tubulin stabilizers in Chapter 1). Discodermalide is, however, described in Chapter 14. It is eyeopening that even those compounds that are currently described as being of synthetic origin were really derived from natural products or from knowledge learned from natural products: the case of the nucleoside HIV inhibitors and their natural-product origins is described in Chapter 7. In Chapter 1, the origin of fluoroquinolones is credited as not being of natural-product origin. I will point out that ciprofloxacin and the fluoroquinolones actually derived from nalidixic acid, which originated from the mother liquor from which quinine was extracted! In addition to well-known natural products of microbial and plant origin, the book has a chapter dedicated to endosymbiotic organisms, including methods to cultivate these organisms and metabolites made by these organisms. Interestingly, in some instances, the close relationship of the microbes and plants through evolution has led to a unity of purpose between them, with both making similar compounds, as in the case of Taxus brevifolia (Yew tree) and Taxomyces andreanne, both of which make taxol. Even more surprisingly, taxol is synthesized by endosymbionts unre-lated to the Yew tree (described in Chapter 15), leading to the conclusion that nature has applied similar chemistries in diverse locations.
Chapters that describe sources that have a rich natural-products heritage, such as China and South America, also point out ethical and intellectual property issues that have slowed the development of natural products. Of interest, the description of multiple biological activities and multiple types of extracts contained in the same herbal medicines that have been used from ancient to modern times in countries such as China and South America is reminiscent of the modern practice of polypharmacy. In addition, many natural products have more than 1 therapeutic activity within a single molecule. These chapters pave the way for exploring without exploitation these resources for the good of all peoples of the earth.
The applications of new technologies, such as isolating DNA from microbes that cannot be cultivated, open new doors, allowing for either expressing genes of interest in cultivatable laboratory microbes or using in silico approaches to decipher new pathways for chemical synthesis. These technologies that can help in the directed creation of new molecules should revive interest in natural products.
There is such a remarkable diversity of molecules that perform the same end activity (i.e., tubulin polymerization and stabilizers should be a pointer to those in HTS and drug discovery) that nature has addressed those targets through multiple chemical synthetic pathways, and it may not be possible to achieve this complexity by de novo synthesis.
The coeditor of the book, Dr. Lixin Zhang, has succinctly described the advantages of screening natural products for new drugs in Chapter 2. The use of natural products as a complementary approach to screening synthetic compounds is encouraged to fuel future drug discovery programs.
The book truly draws out the difficulties of natural products but addresses the methods to overcome these difficulties through modern technologies and tools. This provides an exciting start to a new era of drug discovery. The book is timely, and students, drug discovery staff, pharmaceutical and biotechnology executives, and even pharmaceutical investors reading it will be inspired to drive a paradigm shift in drug discovery. It is time to move back to natural products, combining existing knowledge with modern technologies and combinatorial chemistry and biology, to refill the pipelines of pharmaceutical companies and address many medical needs.
